(Q35076749)

6 August 2017

1 reference

title

The utility of melatonin in reducing cerebral damage resulting from ischemia and reperfusion (English)

1 reference

6 August 2017

0 references

Raymond Tak Fai Cheung

series ordinal

1

1 reference

6 August 2017

1 April 2003

1 reference

Journal of Pineal Research

6 August 2017

1 reference

6 August 2017

34

1 reference

6 August 2017

3

1 reference

6 August 2017

153-160

1 reference

Ischemia-induced neuronal apoptosis

6 August 2017

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00034.X

The changing landscape of ischaemic brain injury mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00034.X

Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00034.X

Current status and perspectives of neuroprotection in ischemic stroke treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00034.X

Cerebral ischemia: from animal studies to clinical practice. Should the methods be reviewed?

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00034.X

Role of calcium in neuronal cell injury: which subcellular compartment is involved?

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00034.X

Reactive oxygen radicals in signaling and damage in the ischemic brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00034.X

Cerebral ischemia and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00034.X

The role of leukocytes following cerebral ischemia: pathogenic variable or bystander reaction to emerging infarct?

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00034.X

Nitric oxide synthase: Aspects concerning structure and catalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00034.X

Biosynthesis of nitric oxide from L-arginine. A pathway for the regulation of cell function and communication

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00034.X

Glutamate, nitric oxide and cell-cell signalling in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00034.X

Nitric oxide synthase in models of focal ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00034.X

Biochemical reactivity of melatonin with reactive oxygen and nitrogen species: a review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00034.X

Pharmacological action of melatonin in shock, inflammation and ischemia/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00034.X

Protective effect of melatonin against hippocampal DNA damage induced by intraperitoneal administration of kainate to rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00034.X

Melatoninergic neuroprotection of the murine periventricular white matter against neonatal excitotoxic challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00034.X

Melatonin prevents ischemia reperfusion injury in hamster cheek pouch microcirculation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00034.X

Pinealectomy aggravates and melatonin administration attenuates brain damage in focal ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00034.X

Effect of melatonin on ischemia reperfusion injury induced by middle cerebral artery occlusion in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00034.X

Pre-treatment with melatonin reduces volume of cerebral infarction in a permanent middle cerebral artery occlusion stroke model in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00034.X

Pretreatment with melatonin reduces volume of cerebral infarction in a rat middle cerebral artery occlusion stroke model

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00034.X

Administration of melatonin after onset of ischemia reduces the volume of cerebral infarction in a rat middle cerebral artery occlusion stroke model

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00034.X

Melatonin reduces nitric oxide level during ischemia but not blood-brain barrier breakdown during reperfusion in a rat middle cerebral artery occlusion stroke model

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00034.X

Enhanced protection by melatonin and meloxicam combination in a middle cerebral artery occlusion model of acute ischemic stroke in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00034.X

Melatonin administration protects CA1 hippocampal neurons after transient forebrain ischemia in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00034.X

Neuroprotective effect of melatonin on brain damage induced by acute global cerebral ischemia in cats

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00034.X

Pinealectomy: behavioral and neuropathological consequences in a chronic cerebral hypoperfusion model

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00034.X

Melatonin protects bovine cerebral endothelial cells from hyperoxia-induced DNA damage and death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00034.X

Melatonin protects primary cultures of rat cortical neurones from NMDA excitotoxicity and hypoxia/reoxygenation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00034.X

Melatonin protects SHSY5Y neuroblastoma cells from cobalt-induced oxidative stress, neurotoxicity and increased beta-amyloid secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00034.X

Melatonin is protective in necrotic but not in caspase-dependent, free radical-independent apoptotic neuronal cell death in primary neuronal cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00034.X

Melatonin protects SHSY5Y neuronal cells but not cultured astrocytes from ischemia due to oxygen and glucose deprivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00034.X

Melatonin and melatonin-progestin combinations alter pituitary-ovarian function in women and can inhibit ovulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00034.X

Pharmacological actions of melatonin in oxygen radical pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00034.X

Melatonin, mitochondria, and cellular bioenergetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00034.X

Intravenous ancrod for treatment of acute ischemic stroke: the STAT study: a randomized controlled trial. Stroke Treatment with Ancrod Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00034.X

Elements of cerebral microvascular ischaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00034.X

Cerebral ischemia and trauma-different etiologies yet similar mechanisms: neuroprotective opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00034.X

Oxidative damage in the central nervous system: protection by melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00034.X

Cyclooxygenase-1 gene knockout does not alter middle cerebral artery occlusion in a mouse stroke model

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00034.X

Glial cell survival is enhanced during melatonin-induced neuroprotection against cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00034.X

Protective effects of melatonin in ischemic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00034.X

Pharmacological strategies in the treatment of cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00034.X

7 January 2021

Selective neuronal vulnerability: morphological and molecular characteristics.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00034.X

7 January 2021

Cerebral ischemia: the microcirculation as trigger and target

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00034.X

7 January 2021

Tissue plasminogen activator for acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00034.X

7 January 2021

Viability thresholds and the penumbra of focal ischemia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00034.X

7 January 2021

Pathophysiology and treatment of focal cerebral ischemia. Part I: Pathophysiology

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00034.X

7 January 2021

Temporal profile of neuronal damage in a model of transient forebrain ischemia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00034.X

7 January 2021

Regional cerebral blood flow and glucose metabolism following transient forebrain ischemia.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00034.X

7 January 2021

Nitric oxide in excitable tissues: physiological roles and disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00034.X

7 January 2021

Apoptosis and the nervous system

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00034.X

7 January 2021

New insights into the mode of action of anti-inflammatory drugs.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00034.X

7 January 2021

Apoptosis and necrosis in cerebrovascular disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00034.X

7 January 2021

Melatonin protects primary cultures of cerebellar granule neurons from kainate but not from N-methyl-D-aspartate excitotoxicity

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00034.X

7 January 2021

N-acetyl-serotonin (normelatonin) and melatonin protect neurons against oxidative challenges and suppress the activity of the transcription factor NF-kappaB.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00034.X

7 January 2021

Melatonin prevents oxidative stress-induced cell death in hippocampal cells

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00034.X

7 January 2021

Neuroprotection by melatonin from kainate-induced excitotoxicity in rats

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00034.X

7 January 2021

In vitro and in vivo protection against kainate-induced excitotoxicity by melatonin

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00034.X

7 January 2021

Increased brain damage after stroke or excitotoxic seizures in melatonin-deficient rats.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00034.X

7 January 2021

Melatonin protects hippocampal neurons in vivo against kainic acid-induced damage in mice.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00034.X

7 January 2021

Oxidative stress as a mechanism for quinolinic acid-induced hippocampal damage: protection by melatonin and deprenyl

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00034.X

7 January 2021

Melatonin prevents increases in neural nitric oxide and cyclic GMP production after transient brain ischemia and reperfusion in the Mongolian gerbil (Meriones unguiculatus).

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00034.X

7 January 2021

Melatonin protects against ischemia and reperfusion-induced oxidative lipid and DNA damage in fetal rat brain.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00034.X

7 January 2021

Melatonin exhibits antioxidant properties in a mouse brain slice model of excitotoxicity

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00034.X

7 January 2021

Melatonin inhibits expression of the inducible NO synthase II in liver and lung and prevents endotoxemia in lipopolysaccharide-induced multiple organ dysfunction syndrome in rats

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00034.X

7 January 2021

10.1034/J.1600-079X.2003.00034.X

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12614473